Indeed, the presence of the senescent phenotype in hepatocytes, determined by the expression of p21, p53 and of apoptosis-related proteins, can be used as prognostic markers and have been shown to correlate with the progression of NAFLD and detrimental clinical outcome [57,58]. The gene discussed is TP53; the disease is metabolic dysfunction-associated steatotic liver disease.